UBS Group AG - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 56 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2021. The put-call ratio across all filers is 0.62 and the average weighting 1.9%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$1,000
-88.9%
350
-84.2%
0.00%
Q1 2022$9,000
-57.1%
2,218
-49.9%
0.00%
Q4 2021$21,000
+600.0%
4,427
+532.4%
0.00%
Q3 2021$3,000
-70.0%
700
-71.2%
0.00%
Q2 2021$10,000
-41.2%
2,427
-36.6%
0.00%
Q1 2021$17,000
-59.5%
3,826
-64.2%
0.00%
Q4 2020$42,000
-20.8%
10,700
-18.2%
0.00%
Q3 2020$53,000
-36.9%
13,082
-34.1%
0.00%
Q2 2020$84,000
-24.3%
19,845
-24.8%
0.00%
Q1 2020$111,000
-9.0%
26,406
-14.7%
0.00%
Q4 2019$122,000
+13.0%
30,972
+152.2%
0.00%
Q3 2019$108,000
+390.9%
12,282
+435.2%
0.00%
Q2 2019$22,0000.0%2,295
-31.9%
0.00%
Q1 2019$22,000
-86.5%
3,369
-80.5%
0.00%
Q4 2018$163,000
-76.0%
17,240
-48.8%
0.00%
Q3 2018$678,000
+226.0%
33,701
+372.1%
0.00%
Q2 2018$208,000
-92.8%
7,138
-92.7%
0.00%
-100.0%
Q1 2018$2,907,000
+482.6%
97,622
+529.3%
0.00%
Q4 2017$499,000
-25.2%
15,513
-19.0%
0.00%
Q3 2017$667,000
-22.0%
19,163
-33.3%
0.00%
Q2 2017$855,000
+375.0%
28,715
+376.1%
0.00%
Q1 2017$180,000
+27.7%
6,031
-25.5%
0.00%
Q4 2016$141,000
-43.4%
8,092
-22.8%
0.00%
Q3 2016$249,000
+33.9%
10,487
-9.8%
0.00%
Q2 2016$186,000
-28.7%
11,625
-6.7%
0.00%
Q1 2016$261,000
-74.5%
12,464
-67.1%
0.00%
-100.0%
Q4 2015$1,023,000
+298.1%
37,887
+309.6%
0.00%
Q3 2015$257,000
-16.3%
9,250
-26.1%
0.00%
Q2 2015$307,000
+403.3%
12,512
+280.2%
0.00%
Q1 2015$61,000
-23.8%
3,291
-23.7%
0.00%
Q4 2014$80,0004,3110.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders